Cargando…

Synergistic antitumour activity of RAF265 and ZSTK474 on human TT medullary thyroid cancer cells

Medullary thyroid cancer (MTC) is an aggressive malignancy responsible for up to 14% of all thyroid cancer-related deaths. It is characterized by point mutations in the rearranged during transfection (RET) proto-oncogene. The activated RET kinase is known to signal via extracellular signal regulated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bertazza, Loris, Barollo, Susi, Radu, Claudia Maria, Cavedon, Elisabetta, Simioni, Paolo, Faggian, Diego, Plebani, Mario, Pelizzo, Maria Rosa, Rubin, Beatrice, Boscaro, Marco, Pezzani, Raffaele, Mian, Caterina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568928/ https://www.ncbi.nlm.nih.gov/pubmed/26081844 http://dx.doi.org/10.1111/jcmm.12612

Ejemplares similares

Novel Prognostic Factors Associated with Cell Cycle Control in Sporadic Medullary Thyroid Cancer Patients
por: Pezzani, Raffaele, et al.
Publicado: (2019)

Serum miR-375 for Diagnostic and Prognostic Purposes in Medullary Thyroid Carcinoma
por: Censi, Simona, et al.
Publicado: (2021)

ZSTK474 Sensitizes Glioblastoma to Temozolomide by Blocking Homologous Recombination Repair
por: Jiao, Wenhui, et al.
Publicado: (2022)

Antitumor profile of the PI3K inhibitor ZSTK474 in human sarcoma cell lines
por: Namatame, Nachi, et al.
Publicado: (2018)

Basal and Calcium-Stimulated Procalcitonin for the Diagnosis of Medullary Thyroid Cancers: Lights and Shadows
por: Censi, Simona, et al.
Publicado: (2021)

Prognostic Impact of miR-224 and RAS Mutations in Medullary Thyroid Carcinoma
por: Cavedon, Elisabetta, et al.
Publicado: (2017)

Validation of miRNAs as diagnostic and prognostic biomarkers, and possible therapeutic targets in medullary thyroid cancers
por: Mondin, Alberto, et al.
Publicado: (2023)

In Vitro Antimetastatic Effect of Phosphatidylinositol 3-Kinase Inhibitor ZSTK474 on Prostate Cancer PC3 Cells
por: Zhao, Wennan, et al.
Publicado: (2013)

In Vitro Antileukemia Activity of ZSTK474 on K562 and Multidrug Resistant K562/A02 Cells
por: Zhou, Qianxiang, et al.
Publicado: (2016)

Antiproliferative effect of ZSTK474 alone or in combination with chemotherapeutic drugs on HL60 and HL60/ADR cells
por: Zhou, Qianxiang, et al.
Publicado: (2017)

Proteomic analysis of phosphoproteins sensitive to a phosphatidylinositol 3-kinase inhibitor, ZSTK474, by using SELDI-TOF MS
por: Akashi, Tetsuyuki, et al.
Publicado: (2009)

Inhibitory effects of ZSTK474, a novel phosphoinositide 3-kinase inhibitor, on osteoclasts and collagen-induced arthritis in mice
por: Toyama, Shoko, et al.
Publicado: (2010)

Dual targeting of glioblastoma multiforme with a proteasome inhibitor (Velcade) and a phosphatidylinositol 3-kinase inhibitor (ZSTK474)
por: LIN, LEHANG, et al.
Publicado: (2013)

Aurora kinases are expressed in medullary thyroid carcinoma (MTC) and their inhibition suppresses in vitro growth and tumorigenicity of the MTC derived cell line TT
por: Baldini, Enke, et al.
Publicado: (2011)

Biological Effects of EF24, a Curcumin Derivative, Alone or Combined with Mitotane in Adrenocortical Tumor Cell Lines
por: Bertazza, Loris, et al.
Publicado: (2019)

Overexpression of L-Type Amino Acid Transporter 1 (LAT1) and 2 (LAT2): Novel Markers of Neuroendocrine Tumors
por: Barollo, Susi, et al.
Publicado: (2016)

Basal expression of insulin-like growth factor 1 receptor determines intrinsic resistance of cancer cells to a phosphatidylinositol 3-kinase inhibitor ZSTK474
por: Isoyama, Sho, et al.
Publicado: (2015)

ZSTK474, a specific class I phosphatidylinositol 3-kinase inhibitor, induces G1 arrest and autophagy in human breast cancer MCF-7 cells
por: Wang, Yaochen, et al.
Publicado: (2016)

Synergistic Antitumour Properties of viscumTT in Alveolar Rhabdomyosarcoma
por: Stammer, Rahel Mascha, et al.
Publicado: (2017)

Changing Dietary Habits in Veneto Region over Two Decades: Still a Long Road to Go to Reach an Iodine-Sufficient Status
por: Censi, Simona, et al.
Publicado: (2020)

Class I PI3K inhibitor ZSTK474 mediates a shift in microglial/macrophage phenotype and inhibits inflammatory response in mice with cerebral ischemia/reperfusion injury
por: Wang, Po, et al.
Publicado: (2016)

The phosphoinositide 3-kinase inhibitor ZSTK474 increases the susceptibility of osteosarcoma cells to oncolytic vesicular stomatitis virus VSVΔ51 via aggravating endoplasmic reticulum stress
por: Jiang, Jinqiong, et al.
Publicado: (2021)

The Effects of Iodine Supplementation in Pregnancy on Iodine Status, Thyroglobulin Levels and Thyroid Function Parameters: Results from a Randomized Controlled Clinical Trial in a Mild-to-Moderate Iodine Deficiency Area
por: Censi, Simona, et al.
Publicado: (2019)

Small-Molecule RAF265 as an Antiviral Therapy Acts against PEDV Infection
por: Wang, Jing, et al.
Publicado: (2022)

Anticancer Effects of Wild Mountain Mentha longifolia Extract in Adrenocortical Tumor Cell Models
por: Patti, Felicia, et al.
Publicado: (2020)

Frequency and Significance of Ras, Tert Promoter, and Braf Mutations in Cytologically Indeterminate Thyroid Nodules: A Monocentric Case Series at a Tertiary-Level Endocrinology Unit
por: Censi, Simona, et al.
Publicado: (2017)

A constitutive active MAPK/ERK pathway due to BRAF(V600E) positively regulates AHR pathway in PTC
por: Occhi, Gianluca, et al.
Publicado: (2015)

Prognostic significance of the sum of the diameters of single foci in multifocal papillary thyroid cancer: the concept of new-old tumor burden
por: Manso, Jacopo, et al.
Publicado: (2020)

Programmed cell death 4 (PDCD4) as a novel prognostic marker for papillary thyroid carcinoma
por: Galuppini, Francesca, et al.
Publicado: (2019)

Sentinel lymph node mapping: current applications and future perspectives in thyroid carcinoma
por: Boschin, Isabella Merante, et al.
Publicado: (2023)

Circulating miR-146a predicts glucocorticoid response in thyroid eye disease
por: Manso, Jacopo, et al.
Publicado: (2023)

Differentiated Thyroid Carcinoma in Pediatric Age: Genetic and Clinical Scenario
por: Galuppini, Francesca, et al.
Publicado: (2019)

The role of the size in thyroid cancer risk stratification
por: Vianello, Federica, et al.
Publicado: (2021)

Overexpression of miR-375 and L-type Amino Acid Transporter 1 in Pheochromocytoma and Their Molecular and Functional Implications
por: Manso, Jacopo, et al.
Publicado: (2022)

Genetic Alterations in Medullary Thyroid Cancer: Diagnostic and Prognostic Markers
por: A, Taccaliti, et al.
Publicado: (2011)

Tumor Suppressor Role of Notch1 and Raf-1 Signaling in Medullary Thyroid Cancer Cells
por: Kunnimalaiyaan, Muthusamy, et al.
Publicado: (2007)

A first‐in‐human phase I, multicenter, open‐label, dose‐escalation study of the oral RAF/VEGFR‐2 inhibitor (RAF265) in locally advanced or metastatic melanoma independent from BRAF mutation status
por: Izar, Benjamin, et al.
Publicado: (2017)

474 Productive and reproductive performance of Goat Breeds of Sindh.
por: Bilal, G, et al.
Publicado: (2018)

Preclinical analysis of the anti-tumor and anti-metastatic effects of Raf265 on colon cancer cells and CD26(+) cancer stem cells in colorectal carcinoma
por: Chow, Ariel KM, et al.
Publicado: (2015)

Antitumour Antibiotics
por: Fox, B. W.
Publicado: (1979)

Cannot write session to /tmp/vufind_sessions/sess_61s1bd7rvd6l5q3i68tbn0msbg